Sign in

CIK 0000730272

  • Large accelerated filer

REPLIGEN CORP

Sign in to watch
Ticker
RGEN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
042729386
Phone
+1 781-449-9560
Business address
41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA, 02453
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$5,953,260
in 5 filings, $6.0M under 10b5-1 plans

Net −$5,953,260. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Loeillot Olivier −$6.0M Chief Executive Officer sold 41% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-05-14 BARTHELEMY NICOLAS Director Grant or award +995 5,436
2026-05-14 BARTHELEMY NICOLAS Director Grant or award · Stock Option (Right to Buy) +2,239 2,239
2025-05-15 BARTHELEMY NICOLAS Director Grant or award +973 4,441
2025-05-15 BARTHELEMY NICOLAS Director Grant or award · Stock Option (Right to Buy) +1,800 1,800
2024-06-14 BARTHELEMY NICOLAS Director Purchase +1,200 $125.45 $151K 4,668
2024-05-16 BARTHELEMY NICOLAS Director Grant or award +701 3,468
2024-05-16 BARTHELEMY NICOLAS Director Grant or award · Stock Option (Right to Buy) +1,376 1,376
2023-05-18 BARTHELEMY NICOLAS Director Grant or award +686 2,767
2023-05-18 BARTHELEMY NICOLAS Director Grant or award · Stock Option (Right to Buy) +1,487 1,487
2022-05-26 BARTHELEMY NICOLAS Director Grant or award +534 2,081
2022-05-26 BARTHELEMY NICOLAS Director Grant or award · Stock Option (Right to Buy) +1,298 1,298

Page 1 of 1 · 11 trades